Evidence-Based Complementary and Alternative Medicine

Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders


Status
Published

Lead Editor

1University of Malakand, Chakdara, Pakistan

2University of Petra, Amman, Jordan

3Indiana University, Bloomington, USA

4University of Swabi, Khyber Pakhtunkhwa, Pakistan

5Abdul Wali Khan University, Mardan, Pakistan


Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders

Description

Neurological disorders are common and represent a major public health problem. Neurological disorders include dementia, epilepsy, headache disorders, multiple sclerosis, and neuroinfections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson’s disease, stroke, and traumatic brain injuries. There are approximately 450 million of world populations suffering from these mental disorders. For example, 50 million people have epilepsy and this number is increasing day by day. The number of people suffering from dementia and memory disorders is projected to be doubled every 20 years. Neurological disorders constitute over 6% of the global burden of disease. This burden is especially high in many low and middle income countries.

Considerable efforts have been made in recent decades to discover substances which can help prevent these serious neurological disorders. Natural products are small molecules found in divergent natural sources. They possess a coveted position in the treatment of all human illnesses including neurological disorders. They are believed to be the single most important source of drug leads. The importance of plant derived natural products for the treatment of neurological disorders is evident by the fact that most of the earlier drugs used for the treatment of neurological disorders were derived from plants including opioids alkaloids, galantamine, anticholinesterases like physostigmine, and neostigmine. During the last decade out of total 26 natural drugs approved, 7 were for the treatment of neurological disorders out of which 3 were for Parkinson’s disease. Thus keeping in view the immense therapeutic potential of natural products, evidence-based complementary and alternative medicine will be publishing special issue on natural products as emerging therapeutic alternative in the treatment of neurological disorders. This special issue invites contributions in all areas of neurological disorders mentioned above.

Potential topics include but are not limited to the following:

  • Sleep disorders
  • Anxiety disorders
  • Memory disorders
  • Alzheimer’s disease
  • Schizophrenia
  • Depressive disorders
  • Epilepsies
  • Parkinsonism
  • Drug dependence
  • Stroke
  • Pain disorders

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 3056847
  • - Editorial

Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders

Nasiara Karim | Heba Abdelhalim | ... | Haroon Khan
  • Special Issue
  • - Volume 2018
  • - Article ID 1709182
  • - Research Article

Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects

Nadia Gulluni | Tania Re | ... | Fabio Firenzuoli
  • Special Issue
  • - Volume 2017
  • - Article ID 6405789
  • - Research Article

Antidepressant-Like Effect of Selected Egyptian Cultivars of Flaxseed Oil on a Rodent Model of Postpartum Depression

Nebal El Tanbouly | Abeer Mohamed El Sayed | ... | Essam Abdel-Sattar
  • Special Issue
  • - Volume 2017
  • - Article ID 7217619
  • - Research Article

Anxiolytic Effect of Citrus aurantium L. in Crack Users

Gabriel Chaves Neto | João Euclides Fernandes Braga | ... | Margareth de Fátima Formiga Melo Diniz
  • Special Issue
  • - Volume 2017
  • - Article ID 8391637
  • - Research Article

Modified Suanzaorentang Had the Treatment Effect for Generalized Anxiety Disorder for the First 4 Weeks of Paroxetine Medication: A Pragmatic Randomized Controlled Study

Ming-Fen Song | Lin-Lin Hu | ... | Yong-Hua Zhang
  • Special Issue
  • - Volume 2017
  • - Article ID 5148219
  • - Research Article

Anticonvulsant and Neuroprotective Activities of Phragmanthera austroarabica Extract in Pentylenetetrazole-Kindled Mice

Hibah M. Aldawsari | Basma G. Eid | ... | Jihan M. Badr
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.